KIAA1324 may be a novel suppressor, being epigenetically downregulated in gastric cancer (Kang et al., 2015); in addition, its high expression in endometrial and pancreatic carcinoma predicts improved survival (Oh et al., 2006; Westin et al., 2009). The gene discussed is ELAPOR1; the disease is exocrine pancreatic carcinoma.